| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
0.8 |
| Metabolic Syndrome |
0 |
0.9 |
| Obesity |
0 |
0.88 |
| Cardiovascular disease |
0 |
0.99 |
| Hypertension |
0 |
0.53 |
| Liver Disease |
0 |
0.51 |
| Cardiovascular Risk Management |
0 |
0.46 |
| Fatty Liver |
0 |
0.46 |
| Liver |
0 |
0.46 |
| Body Mass Index |
0 |
0.39 |
| Metabolism |
0 |
0.26 |
| Cirrhosis |
0 |
0.2 |
| Renal Disease |
0 |
0.19 |
| Chronic Kidney Disease |
0 |
0.17 |
| Renal Failure |
0 |
0.17 |
| Cerebrovascular Accident |
0 |
0.14 |
| Peripheral Artery Disease |
0 |
0.14 |
| Dyslipidemia |
0 |
0.13 |
| Kidney |
0 |
0.13 |
| Michigan |
0 |
0.13 |
| Lipids Management |
0 |
0.09 |
| Microbiome |
0 |
0.08 |
| Alcohol Use |
0 |
0.07 |
| Diabetes Mellitus |
0 |
0.07 |
| Diet |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Hand |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Transplantation |
0 |
0.07 |
| Virginia |
0 |
0.07 |
| Genomic Medicine |
0 |
0.05 |